How S 2020 changes current law

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill expands the use of telehealth services for remote imaging related to chronic eye diseases by amending the Social Security Act.

• 42 U.S.C. 1395m(m)

  and (7) → (7), and (8)

  It adds a new category for telehealth services related to remote imaging for chronic eye disease.

• 42 U.S.C. 1395m(m)

  (8) Treatment of remote imaging for chronic eye disease.--(A) Non-application of originating site requirements.--The requirements described in paragraph (4)(C) shall not apply with respect to telehealth services furnished on or after January 1, 2020, for purposes of providing remote imaging for chronic eye disease, as determined by the Secretary, including diabetic eye disease and glaucoma. Such screenings and services shall include the use of FDA-approved ocular imaging techniques and technologies, including artificial intelligence technologies, shown to support the accurate diagnosis or monitoring or treatment of diabetic retinopathy, glaucoma, or other chronic eye disease, as determined by the Secretary.

  It allows telehealth services for remote imaging of chronic eye diseases without the usual originating site requirements.

• 42 U.S.C. 1395m(m)

  (B) No originating site facility fee for new sites.--No facility fee shall be paid under paragraph (2)(B) to an originating site with respect to a telehealth service described in subparagraph (A) if the originating site does not otherwise meet the requirements for an originating site under paragraph (4)(C).

  It prohibits payment of a facility fee to new originating sites that do not meet established requirements for telehealth services.

• 42 U.S.C. 1395m(m)

  (C) Report.--Not later than 5 years after the date of the enactment of this paragraph, the Secretary shall submit to Congress a report on the impact of this paragraph with respect to telehealth services on--(i) the utilization of health care items and services related to diabetes and glaucoma; (ii) health outcomes related to diabetes and glaucoma; and (iii) the rates of specialty referrals and the rate for completion of a specialty visit within 90 days of referral for individuals with diabetic retinopathy or glaucoma after receiving telehealth services.

  It mandates a report to Congress analyzing the effects of the new telehealth service provisions on diabetes and glaucoma care.